Circulating Th1 and Th17 Cells in Severe Hemophilia A: Associations with Factor VIII Inhibitor Status and Titers

Abstract Purpose Factor VIII (FVIII) inhibitor development is a major complication of replacement therapy in severe hemophilia A (HA). This study investigated circulating T-helper 1 (Th1) and T-helper 17 (Th17) cell frequencies according to inhibitor status and their associations with inhibitor titers. Methods This case-control study included 32 male patients with severe HA (8 inhibitor-positive and 24 inhibitor-negative) and 24 healthy controls. Flow cytometry was used to assess CD4⁺IFN-γ⁺ Th1 and CD4⁺IL-17⁺ Th17 cells and intracellular cytokine mean fluorescence intensity (MFI). Results Overall, Th1 and Th17 cell frequencies and the cytokine MFIs did not differ significantly between HA patients and healthy controls (P > 0.05). Patients with FVIII inhibitors exhibited a significantly lower proportion of Th1 lymphocytes than those without inhibitors (median [IQR]: 2.77% [1.37–2.81] vs. 5.83% [3.47–6.30], *P = 0.003) and healthy controls (2.77% [1.37–2.81] vs. 4.19% [2.88–5.57], *P = 0.014). No significant differences in Th1-cell frequency were observed between inhibitor-negative patients and healthy controls (P > 0.05). Th17-cell percentage and IL-17 MFI did not differ significantly among all groups (P > 0.05). Among inhibitor-positive patients, Th1-cell frequency correlated positively with Th17-cell frequency (r = 0.494, *P = 0.032) and IFN-γ MFI (r = 0.542, *P = 0.016). The proportion of Th1 lymphocytes had a strong inverse correlation with FVIII inhibitor titer (r=-0.708, *P < 0.001). Neither Th1 nor Th17 cell frequency was significantly associated with white blood cell and platelet count, or hemoglobin level. Conclusion Reduced Th1-cell frequency was associated with FVIII inhibitor positivity and higher inhibitor titers. Further studies are needed to validate these results and clarify their clinical significance.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11509238/v1
Primary Topic
Hemophilia Treatment and Research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Circulating Th1 and Th17 Cells in Severe Hemophilia A: Associations with Factor VIII Inhibitor Status and Titers

Amin Shahsavani, Mehdi Kalani, Hossein Golmoghaddam, Nargess Arandi et al.
Research Square
Hemophilia Treatment and Research
preprint

Circulating Th1 and Th17 Cells in Severe Hemophilia A: Associations with Factor VIII Inhibitor Status and Titers

Amin Shahsavani, Mehdi Kalani, Hossein Golmoghaddam, Nargess Arandi, Omid Reza Zekavat, Tahereh Zarei
preprint en

Abstract

Abstract Purpose Factor VIII (FVIII) inhibitor development is a major complication of replacement therapy in severe hemophilia A (HA). This study investigated circulating T-helper 1 (Th1) and T-helper 17 (Th17) cell frequencies according to inhibitor status and their associations with inhibitor titers. Methods This case-control study included 32 male patients with severe HA (8 inhibitor-positive and 24 inhibitor-negative) and 24 healthy controls. Flow cytometry was used to assess CD4⁺IFN-γ⁺ Th1 and CD4⁺IL-17⁺ Th17 cells and intracellular cytokine mean fluorescence intensity (MFI). Results Overall, Th1 and Th17 cell frequencies and the cytokine MFIs did not differ significantly between HA patients and healthy controls (P > 0.05). Patients with FVIII inhibitors exhibited a significantly lower proportion of Th1 lymphocytes than those without inhibitors (median [IQR]: 2.77% [1.37–2.81] vs. 5.83% [3.47–6.30], *P = 0.003) and healthy controls (2.77% [1.37–2.81] vs. 4.19% [2.88–5.57], *P = 0.014). No significant differences in Th1-cell frequency were observed between inhibitor-negative patients and healthy controls (P > 0.05). Th17-cell percentage and IL-17 MFI did not differ significantly among all groups (P > 0.05). Among inhibitor-positive patients, Th1-cell frequency correlated positively with Th17-cell frequency (r = 0.494, *P = 0.032) and IFN-γ MFI (r = 0.542, *P = 0.016). The proportion of Th1 lymphocytes had a strong inverse correlation with FVIII inhibitor titer (r=-0.708, *P < 0.001). Neither Th1 nor Th17 cell frequency was significantly associated with white blood cell and platelet count, or hemoglobin level. Conclusion Reduced Th1-cell frequency was associated with FVIII inhibitor positivity and higher inhibitor titers. Further studies are needed to validate these results and clarify their clinical significance.

Research Square
Shiraz University of Medical Sciences (IR)
Shiraz University of Medical Sciences, Shiraz University
Good health and well-being
Hemophilia Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon